Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-009934
Filing Date
2015-06-17
Accepted
2015-06-17 10:17:45
Documents
1
Period of Report
2015-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3784
  Complete submission text file 0001179110-15-009934.txt   5334
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BARRIER THERAPEUTICS, INC. 600 COLLEGE ROAD EAST, SUITE 3200 PRINCETON NJ 08540
Business Address
VANLENT ANNE (Reporting) CIK: 0001229243 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 15935925